Osteoarthritis Trial, Recruiting NCT06094660 Sponsor: Dijklander Ziekenhuis Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT06094660
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults of any sex, aged over 35, who are not suitable candidates for total knee replacement surgery due to age (too young or too old), other health conditions, or technical reasons related to their anatomy or situation
  • People who score below 30 on the Oxford Knee Score (OKS), a standard questionnaire measuring how well the knee is functioning
  • People experiencing moderate to severe ongoing knee pain — scoring 6 or higher on an 11-point pain scale — either constantly or during movement, despite having tried at least 3 months of conservative treatments such as physiotherapy, pain medications (paracetamol or anti-inflammatories), or steroid injections into the knee joint
  • People with imaging (X-ray or MRI) confirming knee arthritis, rated at a Kellgren-Lawrence score of 2 or higher

Who may not be able to join:

  • People who have previously had nerve ablation (a procedure to deaden nerves) around the knee, or who have had any prior partial, resurfacing, or total knee replacement surgery on the affected knee
  • People with a history of nerve or blood vessel injury near the knee, or a recent injury to the lower limbs
  • People who experience widespread chronic pain throughout their body
  • People with nerve damage affecting multiple nerves (polyneuropathy) or nerve pain radiating down the leg from the spine
  • People who currently have a nerve stimulator device implanted in their body
  • People with an active local or widespread infection, including infection in the bloodstream
  • People with poorly controlled immune system suppression
  • People who have received any injection into the affected knee joint (such as steroids, hyaluronic acid, platelet-rich plasma, or stem cells) within the 90 days before joining the trial
  • People who have had arthroscopic knee surgery (a camera-guided procedure to clean or wash out the joint) within the 180 days before joining the trial
  • People with a very low BMI (under 18.5 kg/m²) or with very little tissue under the skin around the knee, which could make certain treatment procedures unsafe due to risk of skin burns
  • People with known allergies to any substances used during the procedure, including local anaesthetic (lidocaine), phenol, or contrast dye
  • People who have already agreed on and scheduled a date for total knee replacement surgery
  • People identified by the trial investigators as having significant psychosocial difficulties that may affect participation

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gezina Oei, MD, PhD, Academic Medical Centre Amsterdam

Phone: 0031229257257

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Dijklander Ziekenhuis
Registry
ClinicalTrials.gov
Start date
27 November 2023
Est. completion
1 November 2026

Where this trial is recruiting

🇳🇱 Netherlands

Primary endpoints

Knee function measured with the Oxford Knee score (OKS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov